Humana Inc. (NYSE:HUM) Shares Sold by AM Squared Ltd

AM Squared Ltd lowered its stake in Humana Inc. (NYSE:HUM) by 66.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 100 shares of the insurance provider’s stock after selling 200 shares during the quarter. AM Squared Ltd’s holdings in Humana were worth $37,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. Barlow Wealth Partners Inc. purchased a new stake in Humana in the fourth quarter valued at approximately $1,977,000. Intech Investment Management LLC grew its position in Humana by 46.2% in the 4th quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock valued at $19,359,000 after acquiring an additional 13,356 shares in the last quarter. AdvisorShares Investments LLC acquired a new stake in shares of Humana during the fourth quarter worth about $421,000. Sei Investments Co. boosted its stake in shares of Humana by 0.4% in the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock valued at $21,462,000 after purchasing an additional 264 shares during the period. Finally, Cetera Advisors LLC grew its holdings in shares of Humana by 472.1% in the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock valued at $3,501,000 after purchasing an additional 8,333 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

HUM traded up $3.11 during trading hours on Friday, hitting $354.47. 1,135,132 shares of the stock were exchanged, compared to its average volume of 800,611. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The stock has a 50-day simple moving average of $367.67 and a 200-day simple moving average of $346.86. The stock has a market cap of $42.68 billion, a price-to-earnings ratio of 22.07, a price-to-earnings-growth ratio of 3.16 and a beta of 0.51.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company earned $8.94 earnings per share. Analysts anticipate that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be paid a $0.885 dividend. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.00%. Humana’s payout ratio is currently 22.04%.

Wall Street Analyst Weigh In

HUM has been the subject of several analyst reports. Robert W. Baird started coverage on Humana in a research note on Thursday, May 30th. They set a “neutral” rating and a $374.00 target price for the company. Deutsche Bank Aktiengesellschaft upped their price objective on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Bank of America increased their price target on shares of Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a report on Monday, May 20th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a report on Monday, August 19th. Finally, Truist Financial increased their target price on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a report on Monday, July 15th. Thirteen equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $396.35.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.